Skip to main content
logo
Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France flag France · Delayed Price · Currency is EUR
0.3210
-0.0050 (-1.53%)
At close: Aug 21, 2026

EPA:ALOPM Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
1.811.811.641.748.29
Revenue Growth
4.26%10.87%-6.02%-79.03%-
Gross Profit
8.758.75-4.88-6.260.73
Operating Income
5.715.71-7.81-9.94-1.61
Net Income
5.485.48-7.21-8.09-0.23
Earnings Per Share
0.300.30-0.40-0.49-0.01
EPS Growth
-13.32%----

Revenue by Segment
Chart
Fiscal YearTTMFY 2025
Period EndingDec '25 Dec '25
Taxable Services
0.110.11
Products Annexed Activities
0.160.16
Total
0.260.26

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
2.112.115.2710.3413.37
Total Debt
6.386.387.588.832.6
Net Cash (Debt)
-4.27-4.27-2.311.5110.77
Net Cash Growth
----85.98%-
Net Cash Per Share
-0.23-0.23-0.130.090.65

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
482.81%482.81%-298.27%-8.84%
Operating Margin
314.83%314.83%-477.48%-571.55%-19.41%
Pretax Margin
304.13%304.13%-508.27%-566.38%-20.77%
Profit Margin
302.27%302.27%-440.94%-465.04%-2.79%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
1.071.36---
Forward PE
-0.21---
PS Ratio
3.374.127.9317.241.42